Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Exclusive: BGMA chief executive on how CPTPP accession will affect UK medicine manufacturers

Exclusive: BGMA chief executive on how CPTPP accession will affect UK medicine manufacturers
Mark Samuels, CEO of the BGMA

CPTPP membership could attract more suppliers to the UK market, thereby reduce drug shortage risks and lower prices - says BGMA chief executive Mark Samuels 

Last month, the UK secured the final ratification required to join the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP), marking a significant milestone in its international trade relations.

The deal, set to come into force by 15 December 2024, will establish the UK as part of a free trade area spanning five continents and nearly 600 million people.


With more than 99 per cent of UK goods exports to CPTPP members becoming tariff-free, the agreement is poised to boost exports and contribute to the government’s goal of driving economic growth.

In an exclusive interview with Pharmacy Business, Mark Samuels, chief executive of the British Generic Manufacturers Association (BGMA), discussed the impact of the UK’s accession to CPTPP on the pharmaceutical sector, particularly for generic medicine manufacturers.

In many respects, the UK’s accession to CPTPP will not immediately impact medicine manufacturers,” Samuels said.

“CPTPP had already set out the regulatory, intellectual property (IP) and market access rules in the other 11 member countries, and the UK has already worked to the standards framework in the agreement.”

However, Samuels highlighted that CPTPP membership will provide UK manufacturers with greater transparency and clarity regarding regulatory practices in other member countries.

“The biggest benefit will be the enhancement of visibility and clarity on the regulatory processes undertaken by the other CPTPP members, and UK-based manufacturers can expect to be treated according to the standards and rules set out in the CPTPP text,” he told Pharmacy Business.

When asked about how CPTPP membership will influence the global positioning of UK medicine manufacturers, Samuels said:

“The UK is viewed as having high standards of regulatory compliance, with a world-leading IP framework that balances rewarding innovation and promoting fair competition.

“Membership of CPTPP shows the UK as a leader in global trade and can help the UK promote the international best practice standards that we work to more widely.”

Samuels also identified growth opportunities for UK medicines in certain CPTPP member countries, especially as the membership includes a mixture of “developed and developing countries, as well as those with high populations and some that are more sparsely populated.”

He believes that harmonising regulatory standards across member countries would make supply chains more efficient.

“Companies will have their own strategies, but the ultimate game-changer will be developing trade agreements that harmonise regulatory standards and enable single MA dossiers to cover a range of countries without compromising quality.

“Harmonised standards would make supply more efficient, but regulatory and environmental standards must remain high,” Samuels stated.

The BGMA Chief added that joining CPTPP is a good start to exploring this possibility.

This trade agreement is also expected to help reduce the risk of drug shortages and cut down medicine prices.

Samuels expounded: “The UK has always offered relatively low barriers to entry, enabling the NHS to benefit from a plurality of suppliers.

“CPTPP membership might encourage even more companies to supply the UK market, which would be advantageous for the NHS because more suppliers reduce the shortage risk and reduce prices through greater competition.”

By 2040, CPTPP membership is expected to boost the UK economy by approximately £2 billion annually.

With Peru being the sixth member to ratify the UK’s accession, following Japan, Singapore, Chile, New Zealand, and Vietnam, the agreement will take effect by mid-December for these countries.

The Department for Business and Trade is continuing discussions with the remaining member countries to finalise ratifications.

Minister of State for Trade Policy, Douglas Alexander, called it positive news for UK businesses, encouraging them to seize the opportunities that CPTPP membership will create.

Companies are asked to reach out to the Department for Business and Trade to learn more about how CPTPP membership can benefit them.

More For You

Pharmacies have been advised to incorporate technology, automation, and enhanced PMR systems

Pharmacies have been advised to incorporate technology, automation, and enhanced PMR systems

Pic credit: iStock

Pharmacies remain a safe haven for patients, say safety officers

With ongoing issues over funding, workforces being pushed to the limit, patient safety concerns have been growing in the UK healthcare system.

Jackie Giltrow, chair of the Community Pharmacy Patient Safety Group (CP PSG), has reassured that pharmacies remain a safe place for patients, despite the many challenges facing the sector.

Keep ReadingShow less
Arthritis is the leading cause of disability amongst adults

Arthritis is the leading cause of disability amongst adults

Pic credit: iStock

Supporting patient with arthritis

Community pharmacies can not only offer healthy living advice but also stock medication and supplements that give people relief from chronic pain.

Community pharmacists can be a source of knowledge to help individuals that may be suffering from joint complaints, this may be from the specific conditions such osteoarthritis, rheumatoid arthritis, gout or just general aches and pains that come from daily activities.

Keep ReadingShow less
Men in England die nearly four years earlier than women

Men in England die nearly four years earlier than women

Pic credit: iStock

Pharmacies can drive men’s health strategy

With an estimated 65 per cent of men saying they avoid seeking medical attention for as long as possible, community pharmacies can help remove barriers to accessing healthcare.

The government is currently urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

Keep ReadingShow less
Patient care award at the Pharmacy Business Awards

Left to Right: Shailesh Solanki, Stephen Kinnock MP, Pritee Panchmatia, Brian Chambers, chief commercial officer at AAH and Rory Bremner

Driving success through innovation and teamwoWrk

Pritee Panchmatia has been pharmacist for over three decades. She reveals the secret to her success which saw her recognised for excellence in patient care award at the Pharmacy Business Awards.

Embracing technology is essential for improving work efficiency and patient safety, but investing in staff training and development is just as crucial for running a successful business – said Pritee Panchmatia, superintendent pharmacist and director of Howletts Pharmacy.

Keep ReadingShow less
The Importance of Teaching the Facts About Cannabis
https://www.pexels.com/photo/shallow-focus-photography-of-cannabis-plant-606506/

The Importance of Teaching the Facts About Cannabis

Cannabis has transitioned from a controversial substance associated with illicit activities to a widely accepted plant with medicinal benefits and potential recreational use. As the laws surrounding cannabis evolve in many regions, it becomes increasingly crucial to educate the public about its properties, benefits, and potential risks. Understanding cannabis can empower individuals to make informed choices, whether for personal use, health management, or advocacy. This knowledge is particularly important for younger generations who may face different societal perspectives about cannabis. In teaching the facts about this plant, we can cultivate a calmer and more informed dialogue about cannabis use in our communities.

Understanding Cannabis: A Historical Perspective

A significant aspect of cannabis education involves recognizing its historical background. Cannabis has been utilized for thousands of years for various purposes, such as medicine, textiles, and rituals. Ancient civilizations, including the Chinese, Egyptians, and Indians, wrote extensively about cannabis and its uses. The stigma surrounding cannabis began in the 20th century, largely due to prohibition efforts.

Keep ReadingShow less